Halberd Co. (OTCMKTS:HALB – Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 189,400 shares, an increase of 272.8% from the January 31st total of 50,800 shares. Based on an average daily volume of 2,811,300 shares, the […]
Halberd Co. (OTCMKTS:HALB – Get Free Report) saw a large growth in short interest in January. As of January 15th, there was short interest totalling 206,900 shares, a growth of 61.0% from the December 31st total of 128,500 shares. Based on an average daily trading volume, of 6,831,400 shares, the short-interest ratio is presently 0.0 […]
Halberd (OTCMKTS:HALB – Get Free Report) is one of 385 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors? We will compare Halberd to related businesses based on the strength of its earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Valuation & Earnings This table compares […]
Halberd (OTCMKTS:HALB – Free Report) is one of 376 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its peers? We will compare Halberd to similar companies based on the strength of its institutional ownership, profitability, dividends, analyst recommendations, valuation, earnings and risk. Profitability This table compares Halberd and its peers’ net […]
Halberd (OTCMKTS:HALB – Get Rating) is one of 441 public companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare Halberd to similar companies based on the strength of its analyst recommendations, profitability, valuation, risk, earnings, dividends and institutional ownership. Analyst Recommendations This is a breakdown of current recommendations […]